Autres langues Aurobindo Pharma

Actions

AUROPHARMA

INE406A01037

Temps Différé NSE India S.E. Autres places de cotation 09:17:09 17/05/2024			Varia. 5j.	Varia. 1 janv.
1 180 ^INR	+1,77 %		+4,69 %	+8,90 %

08/05	L'entreprise indienne Hindalco envisage de rechercher 1,2 milliard de dollars pour l'introduction en bourse de Novelis, selon Bloomberg News	RE
02/05	Aurobindo Pharma achève la vente des actifs commerciaux de sa filiale américaine	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

India's Hindalco mulls seeking $1.2 bln in Novelis IPO, Bloomberg News reports	08/05
Aurobindo Pharma Completes Sale of US Arm's Business Assets	02/05
Maintainability Of Sister Ship Arrest On The Premise That Both Vessels Are Managed/operated By The Same Entity, While Each Ship Is Owned By Distinct One Ship Company – Bombay High Court	29/04
Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President R&D (Specialty Drug Delivery)	07/04
Aurobindo Pharma Arms Commission Four New Plants in Andhra Pradesh, India	02/04
Aurobindo Pharma Limited Announces Retirement of K. Ragunathan as Chairman of Board of Directors, Effective March 31, 2024	27/03
Indian shares set to track Asian peers higher, eye on Fed meet	20/03
Aurobindo Pharma Gets US FDA Final Nod for Mometasone Furoate Monohydrate Nasal Spray	20/03
Aurobindo Pharma Limited Receives Final Approval from the US Food & Drug Administration	19/03
Aurobindo Pharma Arm Restarts Distribution of Aseptic Products from Unit III	12/03
APL Healthcare Limited Subsidiary of Aurobindo Pharma Limited Announces Unit Inspection Team of World Health Organization Conducts an Inspection at the Unit IV	11/03
Aurobindo Pharma Limited Appoints N. Ravikiran as Chief Business Officer	05/03
Aurobindo Pharma Limited Receives USFDA Approval for Fingolimod Capsules, 0.5 Mg	01/03
Indian shares set to rise on strong domestic growth, in-line US inflation data	01/03
US FDA Completes Inspection of Aurobindo Pharma's Injectibles Unit	01/03
US FDA Clears Aurobindo Pharma Arm's Manufacturing Unit in Telangana, India	16/02
INDIA STOCKS-Auto stocks drive Indian shares higher	16/02
Aurobindo Pharma Limited Receives USFDA Approval for Deflazacort Tablets, 6 mg, 18 mg, 30 mg, and 36 mg	12/02
Aurobindo Pharma Clocks Gains in Fiscal Q3 Consolidated Net Profit	12/02
INDIA STOCKS-Energy shares drag India's blue-chip stocks; small, mid-caps slide	12/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Aurobindo Pharma

Actions

AUROPHARMA

INE406A01037

Autres langues

Filtres